<p>(A) DU145 cells were treated with vehicle, PMS1077 or PMS601 as the indicated concentration (0–80 µM) and then incubated with or without TNF-α (20 ng/ml) for 24 h. Cell viability was determined by MTT assay. (B) DU145 cells were treated with vehicle or PMS1077 (40 and 80 µM), and then incubated with TNF-α (20 ng/ml) for 24 h. Treated cells were observed by differential interference contrast microscope. (C) DU145 cells were treated as (B) and apoptosis analysis was performed by flow cytometry through annexin-V-FITC and Propidium iodide (PI) staining treated cells. (D) DU145 cells were treated with vehicle or PMS1077 (40 and 80 µM), then incubated with TNF-α (20 ng/ml) for 12 h. After treatment, the whole cell lysates were prepared and ana...
<p>(<b>A</b>) The apoptotic effect of CP-P alone or in a combination of CYC treatment was analyzed b...
<p>A. hUC-MSCs (2x10<sup>4</sup> in 96-well plates) were pretreated for 2h with the IAP inhibitor GD...
<p>Cells were treated with or without 2.5 μM MPT0B169 for 24 and 48 h, and the following experiments...
<p>(A) TNF-α induced IκB-α degradation, IκB-α phosphorylation. HEK293T cells were treated with TNF-α...
<p>(A) DU145 cells were pretreated with PMS1077 (50 µM) or TPCA-1(2 µM) for 6 h and followed by TNF-...
<div><p>Our previous studies have demonstrated that PMS1077, a platelet-activating factor (PAF) anta...
Our previous studies have demonstrated that PMS1077, a platelet-activating factor (PAF) antagonist, ...
<p>(A) DU145-NF-κB-Luciferase cells were treated with PMS1077 and its structural analogs at final co...
<p><i>A</i>, Confocal microscopy analysis of <i>in situ</i> cell death experiments. Slices from fres...
<p>HEK293T cells were transiently co-transfected with NF-κB-Firefly luciferase and TK-Renilla Lucife...
<p>(A) Cells were untreated or treated with TNF-α (10 ng/ml) for the indicated time intervals. Phosp...
<p><b>A</b>. Analysis of IKKβ-KA-mediated inhibition of NF-κB activation. Left panel: TNFα-induced N...
<p>(A) Western Blot using the TNF-R1 receptor antibody was performed on cell lysate. (B) PARP cleava...
<p><b>A</b>. Analysis of survivin and Bcl-xL protein and mRNA level. SW620 cells were treated with I...
<p><i>A,</i> Western blot analysis of p53, MDM2 and p21 expression in <i>TP53<sup>Wt</sup></i>/<i>MD...
<p>(<b>A</b>) The apoptotic effect of CP-P alone or in a combination of CYC treatment was analyzed b...
<p>A. hUC-MSCs (2x10<sup>4</sup> in 96-well plates) were pretreated for 2h with the IAP inhibitor GD...
<p>Cells were treated with or without 2.5 μM MPT0B169 for 24 and 48 h, and the following experiments...
<p>(A) TNF-α induced IκB-α degradation, IκB-α phosphorylation. HEK293T cells were treated with TNF-α...
<p>(A) DU145 cells were pretreated with PMS1077 (50 µM) or TPCA-1(2 µM) for 6 h and followed by TNF-...
<div><p>Our previous studies have demonstrated that PMS1077, a platelet-activating factor (PAF) anta...
Our previous studies have demonstrated that PMS1077, a platelet-activating factor (PAF) antagonist, ...
<p>(A) DU145-NF-κB-Luciferase cells were treated with PMS1077 and its structural analogs at final co...
<p><i>A</i>, Confocal microscopy analysis of <i>in situ</i> cell death experiments. Slices from fres...
<p>HEK293T cells were transiently co-transfected with NF-κB-Firefly luciferase and TK-Renilla Lucife...
<p>(A) Cells were untreated or treated with TNF-α (10 ng/ml) for the indicated time intervals. Phosp...
<p><b>A</b>. Analysis of IKKβ-KA-mediated inhibition of NF-κB activation. Left panel: TNFα-induced N...
<p>(A) Western Blot using the TNF-R1 receptor antibody was performed on cell lysate. (B) PARP cleava...
<p><b>A</b>. Analysis of survivin and Bcl-xL protein and mRNA level. SW620 cells were treated with I...
<p><i>A,</i> Western blot analysis of p53, MDM2 and p21 expression in <i>TP53<sup>Wt</sup></i>/<i>MD...
<p>(<b>A</b>) The apoptotic effect of CP-P alone or in a combination of CYC treatment was analyzed b...
<p>A. hUC-MSCs (2x10<sup>4</sup> in 96-well plates) were pretreated for 2h with the IAP inhibitor GD...
<p>Cells were treated with or without 2.5 μM MPT0B169 for 24 and 48 h, and the following experiments...